Search Within
Document Type
107-54-0
Applied Filters:
Keyword:'107-54-0'
Showing 1-30 of 183 results for "107-54-0" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
99 83 60 52 78 107 107
100 107 106 103 41 19 84 22 94 57 15 53 45 65 75 93 43 59 97 53 74 23
96 102 60 71 50 30 22 1 95
The Effective Use of Protein Kinase Inhibitors
99 83 60 52 78 107 107
100 107 106 103 41 19 84 22 94 57 15 53 45 65 75 93 43 59 97 53 74 23
96 102 60 71 50 30 22 1 95
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
111 56 36 106 22 54 31 1201 39 143 33
20 18 24 22 107 53 35 108 23 55 32 1192 39 161 31
std
5
24 17 24 21 106 54 40 103 21
From Farm-to-Fork : Singlepath®Direct Campy Poultry
sediment Buffer
POSITIVE
≥107 cfu/g faeces
Singlepath positive
Singlepath negative
0
20
10^7
6
36 21
5
CFU/g 0
20
User Guide-UFC801008D,UFC801024D,UFC801096D
/mL proteīnu
11,1 mM NaCl
Centrifugēt, lai
koncentrētu
PR05779w Rev 03/24 54 of 107
Darbība
Plūsmas ātrums
Faktori, kas ietekmē plūsmas ātrumu, iekļauj parauga
koncentrāciju
Product Information Sheet - T9777
trypsin
and chymotrypsin is noncompetitive. The Ki for trypsin
(using casein as a substrate) is 5.6 x 107 and the Ki for
α-chymotrypsin (using casein as a substrate) is 5.0 x
107.5,6 This inhibitor blocks
LABORATORY NOTEBOOK ISSUANCE PAGE
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
42
51
.9
96
LABORATORY NOTEBOOK ISSUANCE PAGE
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
42
51
.9
96
LABORATORY NOTEBOOK ISSUANCE PAGE
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
42
51
.9
96
Data Sheet - 77237
et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107- 111 (1993).
Tanimoto, Y. et al., Clin. Exper. Allergy, 22, 1020-1025 (1992).
Leydig
Dental Application Brochure
FCC
141-78-6
Ethylene Glycol 107-21-1
Heptane 142-82-5
Hexane 110-54-3
Isopropyl Alcohol FCC, Food Grade;
meets USP testing
specifications
67-63-0
Methanol 67-56-1
Specially Denatured
Process Guidance - Cellvento BHK-200
a viability of > 95% and a cell density above 1.5×106 cells/mL
- Freeze some cells (WCB 0%), with 1×107 viable cells/mL in
Cellvento® BHK-200 medium + 10% DMSO
- Continue with step 8.
Periodic table A4
Unknown title
S
ta
n
d
:
0
1
/2
0
1
7
W
.2
8
0
7
1
8
The life science business of Merck
Process Guidance Cellvento™ BHK-200 Medium EMDM
with a viability of > 95% and a cell density above 1.5×106 cells/mL
– Freeze some cells (WCB 0%), with 1×107 viable cells/mL in Cellvento™ BHK-200 medium + 10% DMSO
– Continue with step 8.
8th
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
4445 30 1919 31
IPI00022429 a-1-acid glycoprotein 1 precursor 103 4 118 4 94 4 220 5 86 3 168 6 107 3 181 5 62 2 397 7
IPI00020091 a-1-acid glycoprotein 2 precursor 153 4 169 4
Chemical compatibility of Mobius®components
7727-54-0 all aqueous
concentrations
R R L L L R R ND R
Ammonium
Dihydrogen
Phosphate
12-61-0 all aqueous
concentrations
R R R R R R R R
Data Sheet - MAB1637
culture of neural precursors from the ovine central
nervous system (CNS). J. Neuroscience Methods 107: 131-140.
Draberova, E. et al. (1998). Expression of class III beta-tubulin in normal and neoplastic
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
109
114
105
21
3. Pump Cart & Pump
XMO3 & TF2S Pump (1200SU)
107
115
105
115
107
105
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
3d24s2
23 50.942 1910
3407
1.45V
0, 2, 3, 4, 5
[Ar] 3d34s2
24 51.996 1907
2671
1.56Cr
0, 2, 3, 6
[Ar] 3d54s1
25 54.938 1246
2061
1.60Mn
-1, 0, 2, 3, 4
Alkaline Phosphatase Detection Kit
TRA-2-54 Monoclonal Antibody, purified 100µg (Catalog # MAB4354)
11. Murine LIF, 5µg (Catalog # LIF2005), 10µg (Catalog # LIF2010)
12. ESGRO, 1 x 106 units (Catalog # ESG1106), 1 x 107 units
Periodic table Poster
3d24s2
23 50.942 1910
3407
1.45V
0, 2, 3, 4, 5
[Ar] 3d34s2
24 51.996 1907
2671
1.56Cr
0, 2, 3, 6
[Ar] 3d54s1
25 54.938 1246
2061
1.60Mn
-1, 0, 2, 3, 4
READY-TO-ASSAYTM CALCIUM-OPTIMIZED CELLS HUMAN RECOMBINANT CB1 RECEPTOR
CATALOG NUMBER:
HTS019F QUANTITY: 1 vial, 1 mL
LOT NUMBER:
CONCENTRATION: 1 x 107 viable cells/mL
BACKGROUND:
Millipore’s
Reduce Contamination Risks and Simplify Filtration System Design and Operation
actuated 18 times and no turbidity was observed in the TSB flush.
For each challenge test, at least 107 cfu of B. diminuta1 was inoculated into the AMPP cam slot. Following
exposure, 15 mL of TSB was flushed
Antibiotics Profiler
bacterial protein synthesis by binding to the
30S ribosomal subunit.
500105 10 g
100 g
$19
$107
Penicillin/Streptomycin/Amphotericin B
Solution (100X), Tissue Culture Grade
Contains 10,000
READY-TO-ASSAYTM CALCIUM-OPTIMIZED CELLS HUMAN RECOMBINANT CXCR3 CHEMOKINE RECEPTOR
CATALOG NUMBER:
HTS003F QUANTITY: 1 vial, 1 mL
LOT NUMBER:
CONCENTRATION: 1 x 107 viable cells/mL
BACKGROUND:
Millipore’s Ready-To-Assay Calcium-Optimized Cells are GPCR-expressing
Protein Tyrosine Phosphatases- Potential Roles in Disease
d
e
r
:
1
.
8
0
0
.
3
2
5
.
3
0
1
0
(
U
S
)
T
e
c
h
n
i
c
a
l
S
Product Information Sheet - CKH200A
103
107
101-114
Average % of Expected 1:4
Range (%)
105
96-112
102
97-107
105
100-113
100
87-109
106
91-115
Average % of
Product Information Sheet - C2149
).
25. Aldridge, D.C. et al., Chem. Commun. p. 551,
(1973).
26. Pendse, G.S., Experientia, 30, 107, (1974).
27. Padwardhan, S.A. et al., Phytochemistry, 13, 1985
(1974).
28. Deshmukh, P.G. et al
Product Information Sheet - D1641
).
25. Aldridge, D.C. et al., Chem. Commun. p. 551,
(1973).
26. Pendse, G.S., Experientia, 30, 107, (1974).
27. Padwardhan, S.A. et al., Phytochemistry, 13, 1985
(1974).
28. Deshmukh, P.G. et al
Product Information Sheet - C6762
).
25. Aldridge, D.C. et al., Chem. Commun. p. 551,
(1973).
26. Pendse, G.S., Experientia, 30, 107, (1974).
27. Padwardhan, S.A. et al., Phytochemistry, 13, 1985
(1974).
28. Deshmukh, P.G. et al
Page 1 of 7